Ehime Macular Edema Study

Not Applicable

Recruiting

• Conditions: type 2 diabetes mellitus and macular edema; Type 2 diabetes mellitus, Diabetic macular edema

• Registration Number: JPRN-jRCTs061180065
• Lead Sponsor: Shiraishi Atsushi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-19
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with diabetic macular edema
Patients with a CRT of 250 micro m or more in OCT
Patients with corrective eyesight of 0.1 or more
Patients with diabetic retinopathy (simple, pre proliferative)
Patients who have not undergone other treatments for macular edema (anti-VEGF drug, steroid local injection, retinal photocoagulation, intraocular surgery) within 3 months until acquisition

Exclusion Criteria

Patients with diabetic macular edema who need and wish anti-VEGF medication
Patients with diabetic macular edema who need and wish subtenon Tenon's administration of MaQaid OPHTALMIC INJECTION 20 mg (triamcinolone acetonide) medication
Patients with diabetic retinopathy who need Panretinal photocoagulation
Patients with obvious vitreous traction at OCT

Study & Design

• Study Type: Interventional
• Study Design: Not specified